|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Investments at fair value | |||||||||||||||||
| Non-Control / Non-Affiliate investments | |||||||||||||||||
| Affiliate investments | |||||||||||||||||
| Control investments | |||||||||||||||||
| Total investments at fair value | |||||||||||||||||
| Cash (restricted cash of $24,961 and $12,933 as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||||||
| Foreign currencies (cost of $11,574 and $14,922 as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||||||
| Interest and fees receivable | |||||||||||||||||
| Investments funded in advance | |||||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||||
| Derivative assets | |||||||||||||||||
| Credit Support Agreements | |||||||||||||||||
| Foreign Exchange Contract | |||||||||||||||||
| Deferred financing fees | |||||||||||||||||
| Receivable from unsettled transactions | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities: | |||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||
| Interest payable | |||||||||||||||||
| Administrative fees payable | |||||||||||||||||
| Base management fees payable | |||||||||||||||||
| Incentive management fees payable | |||||||||||||||||
| Derivative liabilities | |||||||||||||||||
| Payable from unsettled transactions | |||||||||||||||||
| Borrowings under credit facility | |||||||||||||||||
| Notes payable (net of deferred financing fees) | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net Assets: | |||||||||||||||||
| Common stock, $0.001 par value per share (150,000,000 shares authorized, 104,706,884 shares issued and outstanding as of both September 30, 2026 and December 31, 2025) | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Total distributable earnings (loss) | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Total liabilities and net assets | |||||||||||||||||
| Net asset value per share (in dollars per share) |
Loading...